End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-21 pm EDT
|
5-day change
|
1st Jan Change
|
7.24
CNY
|
-1.50%
|
|
+0.56%
|
-9.16%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,966
|
4,735
|
4,880
|
3,446
|
2,924
|
2,656
|
-
|
-
|
Enterprise Value (EV)
1 |
3,966
|
4,735
|
4,880
|
3,446
|
2,924
|
2,656
|
2,656
|
2,656
|
P/E ratio
|
11.7
x
|
12.1
x
|
15.1
x
|
17.3
x
|
46.9
x
|
26.8
x
|
18.1
x
|
11.5
x
|
Yield
|
-
|
-
|
-
|
2.67%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.4
x
|
1.08
x
|
-
|
0.69
x
|
0.69
x
|
0.53
x
|
0.51
x
|
0.5
x
|
EV / Revenue
|
1.4
x
|
1.08
x
|
-
|
0.69
x
|
0.69
x
|
0.53
x
|
0.51
x
|
0.5
x
|
EV / EBITDA
|
-
|
6.73
x
|
-
|
-
|
7.06
x
|
4.68
x
|
4.11
x
|
3.53
x
|
EV / FCF
|
-
|
-
|
-
|
-37,650,580
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
1.91
x
|
2
x
|
-
|
1.33
x
|
1.13
x
|
0.95
x
|
0.91
x
|
0.87
x
|
Nbr of stocks (in thousands)
|
372,525
|
372,525
|
372,534
|
368,206
|
366,857
|
366,857
|
-
|
-
|
Reference price
2 |
10.65
|
12.71
|
13.10
|
9.360
|
7.970
|
7.240
|
7.240
|
7.240
|
Announcement Date
|
2/27/20
|
4/19/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,833
|
4,388
|
-
|
5,016
|
4,224
|
4,994
|
5,196
|
5,342
|
EBITDA
1 |
-
|
703.3
|
-
|
-
|
414.2
|
567
|
646
|
753
|
EBIT
1 |
354.3
|
493.8
|
-
|
258.6
|
64.29
|
103
|
152
|
238
|
Operating Margin
|
12.51%
|
11.25%
|
-
|
5.16%
|
1.52%
|
2.06%
|
2.93%
|
4.46%
|
Earnings before Tax (EBT)
1 |
365.6
|
490.5
|
-
|
255.3
|
64.33
|
103
|
152
|
238
|
Net income
1 |
321.9
|
386
|
306.9
|
219
|
62.05
|
99
|
146
|
230
|
Net margin
|
11.36%
|
8.8%
|
-
|
4.37%
|
1.47%
|
1.98%
|
2.81%
|
4.31%
|
EPS
2 |
0.9077
|
1.050
|
0.8700
|
0.5400
|
0.1700
|
0.2700
|
0.4000
|
0.6300
|
Free Cash Flow
|
-
|
-
|
-
|
-91.54
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-1.82%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.2500
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
4/19/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-91.5
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17.4%
|
17.5%
|
-
|
8.01%
|
2.23%
|
3.5%
|
5%
|
7.5%
|
ROA (Net income/ Total Assets)
|
-
|
7.75%
|
-
|
-
|
-
|
1.4%
|
2%
|
3.2%
|
Assets
1 |
-
|
4,978
|
-
|
-
|
-
|
7,071
|
7,300
|
7,188
|
Book Value Per Share
2 |
5.560
|
6.360
|
-
|
7.060
|
7.080
|
7.630
|
7.960
|
8.340
|
Cash Flow per Share
|
-
|
2.420
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
373
|
348
|
-
|
734
|
235
|
360
|
368
|
377
|
Capex / Sales
|
13.16%
|
7.93%
|
-
|
14.63%
|
5.57%
|
7.21%
|
7.08%
|
7.06%
|
Announcement Date
|
2/27/20
|
4/19/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
-
|
Last Close Price
7.24
CNY Average target price
8
CNY Spread / Average Target +10.50% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.16% | 367M | | -0.48% | 3.53B | | -7.93% | 1.96B | | -0.55% | 1.81B | | -0.66% | 1.69B | | -9.39% | 1.29B | | +4.48% | 1.19B | | -20.89% | 1.05B | | -5.40% | 979M | | -13.54% | 850M |
Pesticide
|